The DOI matches its Crossref record; 142 of the 146 references it cites were found in a registry or an index.
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
Abstract
OBJECTIVE: Women with polycystic ovary syndrome (PCOS) often have cardiovascular disease (CVD) risk factors. The Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society created a panel to provide evidence-based reviews of studies assessing PCOS-CVD risk relationships and to develop guidelines for preventing CVD. PARTICIPANTS: An expert panel in PCOS and CVD reviewed literature and presented recommendations. EVIDENCE: Only studies comparing PCOS with control patients were included. All electronic databases were searched; reviews included individual studies/databases, systematic reviews, abstracts, and expert data. Articles were excluded if other hyperandrogenic disorders were not excluded, PCOS diagnosis was unclear, controls were not described, or methodology precluded evaluation. Inclusion/exclusion criteria were confirmed by at least two reviewers and arbitrated by a third. CONSENSUS PROCESS: Systematic reviews of CVD risk factors were compiled and submitted for approval to the AE-PCOS Society Board. CONCLUSIONS: Women with PCOS with obesity, cigarette smoking, dyslipidemia, hypertension, impaired glucose tolerance, and subclinical vascular disease are at risk, whereas those with metabolic syndrome and/or type 2 diabetes mellitus are at high risk for CVD. Body mass index, waist circumference, serum lipid/glucose, and blood pressure determinations are recommended for all women with PCOS, as is oral glucose tolerance testing in those with obesity, advanced age, personal history of gestational diabetes, or family history of type 2 diabetes mellitus. Mood disorder assessment is suggested in all PCOS patients. Lifestyle management is recommended for primary CVD prevention, targeting low-density and non-high-density lipoprotein cholesterol and adding insulin-sensitizing and other drugs if dyslipidemia or other risk factors persist.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We did not identify high-quality PCOS-specific evidence to answer the question, hence a clinical consensus recommendation was made based on clinical expertise, an international position statement on CVD risk assessment in PCOS 78 and on national guidelines on absolute CVD risk assessment, 46 management of obesity, 54 lipids 77,79 and hypertension 80 for the general population.”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [78]
In the citing paper
“Previous studies have noted that fasting blood glucose level alone appears to lack sensitivity in screening for prediabetes or DM2 in PCOS, with national and international groups recommending screening all women with PCOS with an OGTT. 78,107”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [78]
Citations
Cites
1 retracted
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
RetractedReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“In two large intervention studies, almost 60% relative risk reduction in conversion to diabetes mellitus occurred in obese individuals (BMI, 30 kg/ m(2)) with IGT randomized to intensive lifestyle modification to reduce body weight by 5–7% (101, 102); less dramatic improvement occurred in less obese individuals (BMI,…”
Background(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery
Sjöström, L., Lindroos, A.-K., Peltonen, M., Torgerson, J., Bouchard, C., Carlsson, B., Dahlgren, S., Larsson, B., Narbro, K., Sjöström, C. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035622 · Cited by 4,457
Research works printed but not linked: 1
- Zawadki, 1992, Diagnostic criteria for polycystic ovary syndrome: towards a rational approach, In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;, 377
Cited by
Sorted by citations
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment
Escobar-Morreale, H. F. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.24 · Cited by 2,083
Self-citationDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Self-citationLegro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
Self-citationCriteria, Prevalence, and Phenotypes of Polycystic Ovary Syndrome
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L., & Azziz, R. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.003 · Cited by 1,358
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Self-citationNational Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
Self-citationPregnancy complications in women with polycystic ovary syndrome
Palomba, S., de Wilde, M. A., Falbo, A., Koster, M. P. H., La Sala, G. B., & Fauser, B. C. J. M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv029 · Cited by 691
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Foretz, M., Guigas, B., & Viollet, B. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0242-2 · Cited by 686
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Self-citationMcCartney, C. R., & Marshall, J. C. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1514916 · Cited by 643
Azziz, R. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002698 · Cited by 573
González, F. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.003 · Cited by 515
Escobar-Morreale, H. F., Carmina, E., Dewailly, D., Gambineri, A., Kelestimur, F., Moghetti, P., Pugeat, M., Qiao, J., Wijeyaratne, C. N., Witchel, S. F., et al. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr042 · Cited by 494
Self-citationLipid Levels in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis
Wild, R. A., Rizzo, M., Clifton, S., & Carmina, E. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.027 · Cited by 477
Self-citationRojas, J., Chávez-Castillo, M., Olivar, L. C., Rojas, M., Morillo, J., Mejias, J. A., Calvo, M. C. C., & Bermúdez, V. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/719050 · Cited by 504
Day, F. R., Hinds, D. A., Tung, J. Y., Stolk, L., Styrkarsdottir, U., Saxena, R., Bjonnes, A., Broer, L., Dunger, D. B., Halldorsson, B. V., et al. (2015) · Nature Communications · doi:10.1038/ncomms9464 · Cited by 459
Tata, B., Mimouni, N. E. H., Barbotin, A.-L., Malone, S. A., Loyens, A., Pigny, P., Dewailly, D., Catteau-Jonard, S., Sundström-Poromaa, I., Piltonen, T. T., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0035-5 · Cited by 434
Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
Wekker, V, van Dammen, L., Koning, A., Heida, K. Y., Painter, R. C., Limpens, J., Laven, J. S. E., Roeters van Lennep, J. E., Roseboom, T. J., & Hoek, A. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa029 · Cited by 425
Osibogun, O., Ogunmoroti, O., & Michos, E. D. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.08.010 · Cited by 423
The Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
Hart, R., & Doherty, D. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3886 · Cited by 391
Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline
Teede, H. J., Misso, M. L., Deeks, A. A., Moran, L. J., Stuckey, B. G. A., Wong, J. L. A., Norman, R. J., Costello, M. F., & Groups, O. B. O. T. G. D. (2011) · Medical Journal of Australia · doi:10.5694/mja11.10915 · Cited by 379
Self-citationVisceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction
Amato, M., & Giordano, C. (2014) · International Journal of Endocrinology · doi:10.1155/2014/730827 · Cited by 341
Regensteiner, J. G., Golden, S., Huebschmann, A. G., Barrett-Connor, E., Chang, A. Y., Chyun, D., Fox, C. S., Kim, C., Mehta, N., Reckelhoff, J. F., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000343 · Cited by 334
Poly Cystic Ovarian Syndrome: An Updated Overview
Hayek, S. E., Bitar, L., Hamdar, L., Mirza, F., & Daoud, G. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00124 · Cited by 342
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
Randeva, H. S., Tan, B. K., Weickert, M. O., Lois, K. B., Nestler, J. E., Sattar, N. A., & Lehnert, H. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1003 · Cited by 336
Gut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity
Insenser, M., Murri, M., del Campo, R., Martínez-García, M. Á., Fernández-Durán, E., & Escobar-Morreale, H. F. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02799 · Cited by 312
Self-citationDeconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
Complications and challenges associated with polycystic ovary syndrome: current perspectives
Palomba, S., Santagni, S., Falbo, A., & La Sala, G. B. (2015) · International Journal of Women's Health · doi:10.2147/ijwh.s70314 · Cited by 287
Xu, Y., & Qiao, J. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/9240569 · Cited by 329
Obesity and PCOS: Implications for Diagnosis and Treatment
Legro, R. S. (2012) · Seminars in Reproductive Medicine · doi:10.1055/s-0032-1328878 · Cited by 285
Gonadotropin regulation by pulsatile GnRH: Signaling and gene expression
Stamatiades, G. A., & Kaiser, U. B. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.10.015 · Cited by 293
Lauritsen, M. P., Bentzen, J. G., Pinborg, A., Loft, A., Forman, J. L., Thuesen, L. L., Cohen, A., Hougaard, D. M., & Nyboe Andersen, A. (2014) · Human Reproduction · doi:10.1093/humrep/det469 · Cited by 334
Polycystic ovary syndrome and mitochondrial dysfunction
Zhang, J., Bao, Y.-G., Zhou, X., & Zheng, L. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0509-4 · Cited by 273
Polycystic ovary syndrome is transmitted via a transgenerational epigenetic process
Mimouni, N. E. H., Paiva, I., Barbotin, A., Timzoura, F. E., Plassard, D., Gras, S. L., Ternier, G., Pigny, P., Catteau-Jonard, S., Simon, V., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.004 · Cited by 263
Metabolic risk in PCOS: Phenotype and adiposity impact
Moran, L. J., Norman, R. J., & Teede, H. J. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.12.003 · Cited by 245
Self-citationMeta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome
Toulis, K. A., Goulis, D. G., Mintziori, G., Kintiraki, E., Eukarpidis, E., Mouratoglou, S., Pavlaki, A., Stergianos, S., Poulasouchidou, M., Tzellos, T., et al. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmr025 · Cited by 229
Sheep models of polycystic ovary syndrome phenotype
Padmanabhan, V., & Veiga‐Lopez, A. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.005 · Cited by 222
Daan, N. M. P., Louwers, Y. V., Koster, M. P. H., Eijkemans, M. J. C., de Rijke, Y. B., Lentjes, E. W. G., Fauser, B. C. J. M., & Laven, J. S. E. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.08.001 · Cited by 217
Kauffman, A. S., Thackray, V. G., Ryan, G. E., Tolson, K. P., Glidewell-Kenney, C., Semaan, S. J., Poling, M. C., Iwata, N., Breen, K. M., Dulęba, A. J., et al. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.115.131631 · Cited by 216
Dokras, A., Clifton, S., Futterweit, W., & Wild, R. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.10.022 · Cited by 209
Self-citationSaadia, Z. (2020) · Medical Archives · doi:10.5455/medarh.2020.74.289-293 · Cited by 209
Kumarendran, B., O’Reilly, M. W., Manolopoulos, K. N., Toulis, K. A., Gokhale, K. M., Sitch, A. J., Wijeyaratne, C. N., Coomarasamy, A., Arlt, W., & Nirantharakumar, K. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002542 · Cited by 206
Dobrowolski, P., Prejbisz, A., Kuryłowicz, A., Baska, A., Burchardt, P., Chlebus, K., Dzida, G. J., Jankowski, P., Jaroszewicz, J., Jaworski, P., et al. (2022) · Archives of Medical Science · doi:10.5114/aoms/152921 · Cited by 236
Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
Glintborg, D., Rubin, K. H., Nybo, M., Abrahamsen, B., & Andersen, M. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0680-5 · Cited by 200
Rubin, K. H., Glintborg, D., Nybo, M., Abrahamsen, B., & Andersen, M. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01354 · Cited by 195
Carmina, E., Dewailly, D., Escobar-Morreale, H. F., Keleştimur, F., Morán, C., Oberfield, S. E., Witchel, S. F., & Azziz, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx014 · Cited by 206
Self-citationThe management of patients with polycystic ovary syndrome
Jayasena, C. N., & Franks, S. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.102 · Cited by 196
Dennett, C. C., & Simon, J. (2015) · Diabetes Spectrum · doi:10.2337/diaspect.28.2.116 · Cited by 196
Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease
Guan, C. S., Zahid, S., Minhas, A. S., Ouyang, P., Vaught, A. “. J., Baker, V. L., & Michos, E. D. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.009 · Cited by 218
Mani, H., Levy, M. J., Davies, M. J., Morris, D. H., Gray, L. J., Bankart, J., Blackledge, H., Khunti, K. K., & Howlett, T. A. (2012) · Clinical Endocrinology · doi:10.1111/cen.12068 · Cited by 192
Polycystic ovary syndrome and environmental toxins
Rutkowska, A. Z., & Diamanti‐Kandarakis, E. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.08.031 · Cited by 199
Self-citationDyslipidemia in women with polycystic ovary syndrome
Kim, J., & Choi, Y. M. (2013) · Obstetrics & Gynecology Science · doi:10.5468/ogs.2013.56.3.137 · Cited by 190
on behalf of the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC), Sacco, S., Merki‐Feld, G. S., Ægidius, K. L., Bitzer, J., Canonico, M., Kurth, T., Lampl, C., Lidegaard, Ø., MacGregor, E. A., et al. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0815-1 · Cited by 193
PCOS Forum: research in polycystic ovary syndrome today and tomorrow
Pasquali, R., Stener‐Victorin, E., Yıldız, B. O., Dulęba, A. J., Hoeger, K. M., Mason, H. D., Homburg, R., Hickey, T. E., Franks, S., Tapanainen, J. S., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03956.x · Cited by 188
Self-citationProgesterone Actions and Resistance in Gynecological Disorders
MacLean, J. A., & Hayashi, K. (2022) · Cells · doi:10.3390/cells11040647 · Cited by 199
The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome
Kakoly, N. S., Earnest, A., Teede, H. J., Moran, L. J., & Joham, A. E. (2019) · Diabetes Care · doi:10.2337/dc18-1738 · Cited by 174
Nonalcoholic fatty liver disease and polycystic ovary syndrome
Vassilatou, E. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8351 · Cited by 176
Newman, C. B., Blaha, M. J., Boord, J. B., Cariou, B., Chait, A., Fein, H. G., Ginsberg, H. N., Goldberg, I. J., Murad, M. H., Subramanian, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa674 · Cited by 182
Meyer, M. L., Malek, A. M., Wild, R. A., Korytkowski, M. T., & Talbott, E. O. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr046 · Cited by 175
Self-citationBanaszewska, B., Wrotyńska-Barczyńska, J., Spaczynski, R. Z., Pawelczyk, L., & Duleba, A. J. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1858 · Cited by 173
Comorbidities and complications of polycystic ovary syndrome: An overview of systematic reviews
Gilbert, E. W., Tay, C. T., Hiam, D. S., Teede, H. J., & Moran, L. J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13828 · Cited by 166
Ollila, M.-M. E., West, S., Keinänen-Kiukaanniemi, S., Jokelainen, J., Auvinen, J., Puukka, K., Ruokonen, A., Järvelin, M.-R., Tapanainen, J. S., Franks, S., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dew329 · Cited by 165
Exercise Interventions in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
Patten, R. K., Boyle, R. A., Moholdt, T. T., Kiel, I. A., Hopkins, W. G., Harrison, C. L., & Stepto, N. K. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00606 · Cited by 195
Oh, J., Sung, Y., & Lee, H. J. (2013) · Obesity · doi:10.1002/oby.20096 · Cited by 154
Is foetal hyperexposure to androgens a cause of PCOS?
Filippou, P., & Homburg, R. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx013 · Cited by 152
Bednarz, K., Kowalczyk, K., Cwynar, M., Czapla, D., Czarkowski, W., Kmita, D., Nowak, A., & Madej, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084334 · Cited by 148
Dysregulation of immune response in PCOS organ system
Wang, J., Yin, T., & Liu, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1169232 · Cited by 157
Asemi, Z., Foroozanfard, F., Hashemi, T., Bahmani, F., Jamilian, M., & Esmaillzadeh, A. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.09.015 · Cited by 139
Advanced glycation end products and their relevance in female reproduction
Merhi, Z. O. (2013) · Human Reproduction · doi:10.1093/humrep/det383 · Cited by 137
Health and fertility in World Health Organization group 2 anovulatory women
ESHRE Capri Workshop Group, Baird, D. T., Balen, A., Escobar-Morreale, H. F., Evers, J. L. H., Fauser, B. C. J. M., Franks, S., Glasier, A. F., Homburg, R., Vecchia, C. L., et al. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms019 · Cited by 140
Self-citationCardiovascular disease risk in women with PCOS
Dokras, A. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.009 · Cited by 132
Self-citationPolycystic Ovary Syndrome: Effect and Mechanisms of Acupuncture for Ovulation Induction
Johansson, J., & Stener‐Victorin, E. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/762615 · Cited by 134
Eilertsen, T., Vanky, E., & Carlsen, S. M. (2012) · Human Reproduction · doi:10.1093/humrep/des213 · Cited by 134
Criteria, phenotypes and prevalence of polycystic ovary syndrome
Belenkaia, L. V., Лазарева, Л. М., Walker, W., Lizneva, D., & Сутурина, Л. В. (2019) · Minerva Obstetrics and Gynecology · doi:10.23736/s0026-4784.19.04404-6 · Cited by 133
Hyperandrogenic origins of polycystic ovary syndrome-Implications for Pathophysiology and Therapy
Abbott, D. H., Dumesic, D. A., & Levine, J. E. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1576522 · Cited by 131
Self-citationMarkers of insulin resistance in Polycystic ovary syndrome women: An update
Amisi, C. A. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i3.129 · Cited by 158
Diagnosis and Management of Endometrial Hyperplasia
Armstrong, A. J., Hurd, W. W., Elguero, S., Barker, N. M., & Zanotti, K. M. (2012) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2012.05.009 · Cited by 131
Mood and anxiety disorders in women with PCOS.
Dokras, A. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.008 · Cited by 128
Self-citationMeun, C., Franco, O. H., Dhana, K., Jaspers, L., Muka, T., Louwers, Y., Ikram, M. A., Fauser, B. C. J. M., Kavousi, M., & Laven, J. S. E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02421 · Cited by 126
Orio, F., Muscogiuri, G., Nese, C., Palomba, S., Savastano, S., Tafuri, D., Colarieti, G., La Sala, G., Colao, A., & Yildiz, B. O. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.08.026 · Cited by 126
Wattar, B. A. A., Fisher, M., Bevington, L., Talaulikar, V., Davies, M., Conway, G., & Yasmin, E. (2021) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/clinem/dgab232 · Cited by 101
Type 1 Diabetes and Polycystic Ovary Syndrome: Systematic Review and Meta-analysis
Escobar-Morreale, H. F., & Roldán-Martín, M. B. (2016) · Diabetes Care · doi:10.2337/dc15-2577 · Cited by 123
Self-citationDiagnosis of Polycystic Ovary Syndrome
Chang, S., & Dunaif, A. E. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.002 · Cited by 146
Borruel, S., Fernández-Durán, E., Alpañés, M., Martí, D., Álvarez-Blasco, F., Luque-Ramírez, M., & Escobar-Morreale, H. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3698 · Cited by 122
Self-citationAssociation between PCOS and autoimmune thyroid disease: a systematic review and meta-analysis
Romitti, M., Fabris, V. C., Ziegelmann, P. K., Maia, A. L., & Spritzer, P. M. (2018) · Endocrine Connections · doi:10.1530/ec-18-0309 · Cited by 124
Kazemi, M., McBreairty, L. E., Chizen, D. R., Pierson, R. A., Chilibeck, P. D., & Zello, G. A. (2018) · Nutrients · doi:10.3390/nu10101387 · Cited by 118
Wild, R. A. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.002 · Cited by 117
Self-citationAn integrative toxicogenomic analysis of plastic additives
Sendra, M., Pereiro, P., Figueras, A. J., & Novoa, B. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124975 · Cited by 121
Skałba, P., Cygal, A., Madej, P., Dąbkowska-Huć, A., Sikora, J., Martirosian, G., Romanik, M. K., & Olszanecka‐Glinianowicz, M. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.06.006 · Cited by 118
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0252 · Cited by 113
Self-citationLin, A., Kazemi, M., Jarrett, B. Y., Brink, H. V., Hoeger, K. M., Spandorfer, S. D., & Lujan, M. E. (2019) · Nutrients · doi:10.3390/nu11112711 · Cited by 118
Lerchbaum, E., Schwetz, V., Rabe, T., Giuliani, A., & Obermayer-Pietsch, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108263 · Cited by 110
Zhu, S., Zhang, B., Jiang, X., Li, Z., Zhao, S., Cui, L., & Chen, Z.-J. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.09.013 · Cited by 109
Escobar-Morreale, H. F., Samino, S., Insenser, M. R., Vinaixa, M., Luque‐Ramírez, M., Lasunción, M. A., & Correig, X. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.176396 · Cited by 109
Self-citationPuurunen, J., Piltonen, T., Morin-Papunen, L., Perheentupa, A., Järvelä, I., Ruokonen, A., & Tapanainen, J. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0039 · Cited by 108
Effects of Simvastatin and Metformin on Polycystic Ovary Syndrome after Six Months of Treatment
Banaszewska, B., Pawelczyk, L. A., Spaczyński, R., & Dulęba, A. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0501 · Cited by 110
Longterm management of Polycystic Ovarian Syndrome (PCOS)
Bates, G. W., & Legro, R. S. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.029 · Cited by 106
Nonhuman primate models of polycystic ovary syndrome
Abbott, D. H., Nicol, L. E., Levine, J. E., Xu, N., Goodarzi, M. O., & Dumesic, D. A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.013 · Cited by 111
Self-citation
Metadata
- Authors
- Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A.
- Affiliations
- OU Health (US)
- University of Palermo (IT)
- University of Athens Medical School (E.D.-K.), 11527 Athens, Greece
- University of Pennsylvania (US)
- Hospital Ramon y Cajal (H.F.E.-M.), 28034 Madrid, Spain
- Icahn School of Medicine at Mount Sinai (US)
- Columbia University (R.L.), New York, New York 10027
- The University of Adelaide (AU)
- University of Pittsburgh (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Carmina, Enrico
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-05-01
- Volume
- 95
- Issue
- 5
- Pages
- 2038-2049
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2105749473
- Semantic Scholar
- 5556ce96457d5a9ef1f00894a9f61047e5c6afb4
- Cited by
- 1,010
- References
- 146
- Citations by year
- 2026: 34 · 2025: 47 · 2024: 45 · 2023: 62 · 2022: 77 · 2021: 52 · 2020: 56 · 2019: 73 · 2018: 61 · 2017: 58 · 2016: 62 · 2015: 89 · 2014: 85 · 2013: 69 · 2012: 62
- FWCI
- 79.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- polycystic ovary syndrome, cardiovascular risk, cardiovascular disease prevention, hyperandrogenism, obesity, dyslipidemia, hypertension, impaired glucose tolerance, metabolic syndrome, type 2 diabetes, subclinical vascular disease, body mass index, waist circumference, oral glucose tolerance test, mood disorders, lifestyle management, insulin-sensitizing drugs, cardiovascular risk assessment
- MeSH terms
- Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Polycystic Ovary Syndrome, Risk Factors, Body Mass Index, Glucose Intolerance, Risk Assessment, Waist-Hip Ratio, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
